XML 67 R51.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 19, 2018
Reclassified from line of credit to Notes payable $ 123,409    
Financing lease right-of-use asset 164,859    
Payable to actuarial expert   $ 408,665  
VAT net receivable and payable balance 534,263 187,512  
Long-term liability 377,264 408,665  
Allowance for doubtful accounts 22,799,219 19,686,091  
Cash on hand 15,067 48,590  
Foreign accounts 293,040 1,047,738  
Sales to Medihelm   367,000  
Other Income 0 928  
Depreciation expense 387,036 353,043  
Impairment loss 291,980 0  
Other current liabilities 3,350,173 3,474,096  
Amortization expense 793,836 239,841  
Goodwill 49,697 49,697 $ 49,697
Intangibles Assets [Member]      
Impairment loss 291,980 0  
Customer advances payment      
Other current liabilities 363,708 $ 451,575  
ICC International Cannabis Corp [Member]      
Equity method investment aggregate cost $ 0    
Equity method investment shares acquired, shares 3,000,000 3,000,000  
Closing price $ 0 $ 0  
National Bank of Greece [Member]      
Equity method investment aggregate cost $ 12,766 $ 11,596  
Equity method investment shares acquired, shares 16,666 16,666  
Closing price $ 0.79 $ 0.70  
Pancreta Bank [Member]      
Equity method investment aggregate cost $ 7,665 $ 8,479  
Medihelm S.A. [Member]      
Other Income $ 367,000    
Greece [Member]      
Income tax rate   22.00%  
United Kingdom Of England [Member]      
Income tax rate   25.00%